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Abstract
Background: E-cadherin is a major component of adherens junctions. Impaired expression of E-cadherin in the small
intestine and colon has been linked to a disturbed intestinal homeostasis and barrier function. Down-regulation of E-
cadherin is associated with the pathogenesis of infections with enteropathogenic bacteria and Crohn’s disease.
Methods and Findings: To genetically clarify the function of E-cadherin in intestinal homeostasis and maintenance of the
epithelial defense line, the Cdh1 gene was conditionally inactivated in the mouse intestinal epithelium. Inactivation of the
Cdh1 gene in the small intestine and colon resulted in bloody diarrhea associated with enhanced apoptosis and cell
shedding, causing life-threatening disease within 6 days. Loss of E-cadherin led cells migrate faster along the crypt-villus axis
and perturbed cellular differentiation. Maturation and positioning of goblet cells and Paneth cells, the main cell lineage of
the intestinal innate immune system, was severely disturbed. The expression of anti-bacterial cryptidins was reduced and
mice showed a deficiency in clearing enteropathogenic bacteria from the intestinal lumen.
Conclusion: These results highlight the central function of E-cadherin in the maintenance of two components of the
intestinal epithelial defense: E-cadherin is required for the proper function of the intestinal epithelial lining by providing
mechanical integrity and is a prerequisite for the proper maturation of Paneth and goblet cells.
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Introduction
The intestinal epithelial lining is subject to continuous chemical,
physical and biological insults. Therefore, an integral component of
intestinal homeostasis is maintenance and repair of the epithelial
barrier itself. This barrier is constituted by three main components:
The intestinal epithelial cells themselves, mucins and antibacterial
products secreted by these, and the adaptive immune response [1].
The gastrointestinal epithelial lining consists of a monolayer of cells
that undergoes rapid and continuous self-renewal from the base of
the crypts, where multipotent stem cells reside [2,3]. The small
intestinal epithelium is composed of four distinct differentiated cell
types: absorptive enterocytes, mucus-producing goblet cells, hor-
mone-secreting enteroendocrine cells, and antibacterial peptide-
secreting Paneth cells which in contrast to the other cell lineages
remain at the crypt base. The continuous production of new cells is
balanced by apoptosis at the luminal side, resulting in a cellular turn
over rate of three to five days in the mouse.
Intercellular junctions are a major prerequisite for tissue
integrity and tissue polarization. The apical junctional complex
of the intestinal epithelium is constituted by tight junctions,
adherens junctions, and desmosomes [4]. Tight junctions are
continuous, circumferential belt-like structures that form a
permeability barrier at the apical end of the intercellular space.
Adherens junctions reside immediately subadjacent to tight
junctions and play an important role in cell recognition and in
mediating intercellular associations. Desmosomes, which are
located below adherens junctions, are spot-like intercellular
junctions. Especially in stratified epithelia like the epidermis they
provide strong intercellular association [5].
The major constituent of adherens junctions is E-cadherin. E-
cadherin forms homophilic cell-cell interactions and intracellularly
binds to catenins (b-catenin, plakoglobin, p120-catenin) which link
the transmembranous E-cadherin via a-catenin to the actin
cytoskeleton [6]. E-cadherin elicits many functions in tissue
morphogenesis and is essential in embryo development [7]. Loss
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of E-cadherin function in the intestine has been linked to
pathological processes. Several studies have reported reduced
expression of E-cadherin in inflamed epithelium of patients with
Crohn’s disease and ulcerative colitis [8–10]. Especially in Crohn’s
disease the altered epithelial barrier is believed to be a primary
factor in the development of the disease [11]. Recently,
polymorphisms in the CDH1 gene resulting in truncated and
intracellularly mis-localized E-cadherin have been identified in
patients with Crohn’s disease [12]. Moreover, during progression
of colorectal and other tumors a switch in cadherin expression
from E-cadherin to N-cadherin is observed coinciding with the
transition from an epithelial to a mesenchymal phenotype leading
to an increase in the invasive capabilities of cancer cells [6] and
inactivation of one E-cadherin allele enhances tumor initiation in
mice carrying a mutated adenomatous polyposis coli (APC) gene
[13].
To date E-cadherin has not been directly targeted in the mouse
intestine to clarify its role in this tissue. Indirect data generated by
over-expression of a dominant-negative N-cadherin or targeting
p120-catenin suggest an important role in intestinal homeostasis
[14,15]. To genetically clarify the role of E-cadherin in the
homeostasis of the intestinal epithelium, we inactivated the Cdh1
gene in the mouse small intestine and colon by using the Cre-LoxP
system. We report here that loss of E-cadherin expression results in
loss of adherens junctions and desmosomes, leading to apoptosis
and shedding of cells. Moreover, positioning and maturation of
Paneth and goblet cells is severely impaired and the number of
goblet cells is reduced. This results in the deficiency in clearing
pathogenic bacteria from the intestinal lumen. Our data clarify E-
cadherin’s essential role in the homeostasis of small and large
intestine and its critical contribution to the intestinal epithelial
defense line.
Materials and Methods
Ethics Statement
The maintenance and breeding of mouse lines and all
experiments were approved by the Committee on Animal Health
and Care of the local governmental body of the state of Upper
Bavaria (Regierung von Oberbayern; TA087/09) and performed
in strict compliance with the EEC recommendations for the care
and use of laboratory animals (European Communities Council
Directive of November 24, 1986 [86/609/EEC]).
Animals
Mice homozygous for the floxed E-cadherin allele Cdh1fl/fl [16]
were bred with animals carrying the Villin-Cre-ERT2 transgene
[17], litters were genotyped by PCR as described in the original
publications. Subsequently, double heterozygous Villin-Cre-
ERT2;Cdh1wt/fl animals were mated with Cdh1fl/fl animals to
generate Villin-Cre-ERT2;Cdh1fl/fl mice. From the same crossings,
animals carrying one wild-type E-cadherin allele and mice lacking
the Cre transgene were obtained which served as control animals.
All mice were in the C57BL/6 background. Animals were
maintained under specific pathogen-free conditions in a closed
barrier system and had free access to a standard rodent diet
(V1534, Ssniff, Soest, Germany) and water.
Bioluminescent yersiniae were constructed by integrating the
LuxCDABE operon under the L-arabinose-inducible araBAD
promoter (PBAD) downstream of glmS in Yersinia enterocolitica WA-
C(pYV::Cm) as described previously [18]. Six- to 8-week-old
female Cre+Cdh1fl/fl and control mice (Cre+Cdh1wt/fl) were infected
orally with the bioluminescent yersiniae [18] from frozen stock
suspensions. These were prepared by growth to stationary phase in
LB medium at 27uC and freezing the bacteria in 15% glycerol at
280uC. After appropriate dilutions, bacteria were washed twice
with phosphate-buffered saline and mice were fed 50 ml of the
solution containing 109 CFU with a pipette to the back of the
oropharynx after fasting for 16 h. To induce luminescence of
yersiniae, mice were intraperitoneally injected with 120 mg L-
arabinose in PBS as described previously [18]. Detection of
luminescence was performed with the IVIS Lumina System
(Caliper Life Sciences, Mainz, Germany).The levels of coloniza-
tion of Peyer’s patches and small intestinal lumina were
determined by plating of serial dilutions onto Mueller-Hinton
agar for 36 h at 27uC as described previously [19].
Induction of recombination and BrdU labeling
4-OH-tamoxifen (Sigma, Deisenhofen Germany) was dissolved
in corn oil (Sigma) (final concentration 10 mg/ml). Mice received
1 mg tamoxifen per intraperitoneal injection either for 3 days or 5
days in a row or on days 1, 2, 5, and 8. Mice were sacrificed for
analysis on days 4, 6 or 12, respectively, after start of tamoxifen
injections. To analyze cell proliferation in the intestine, animals
received a single intraperitoneal injection of BrdU (Roche
Diagnostics, Mannheim, Germany; 30 mg/kg body weight)
1 hour or 24 hours prior to sacrifice.
Tissue processing, immunohistochemistry,
immunofluorescence and electron microscopy
At different time points after tamoxifen injection, anaesthetized
mice were sacrificed by exsanguination under isoflurane anesthe-
sia. The intestine was removed immediately, carefully trimmed
free of adjacent tissues, and cleared of stool. The intestines were
fixed in 4% paraformaldehyde (in PBS) in the form of ‘‘swiss rolls’’
[20], dehydrated and embedded in paraffin. From the paraffin-
embedded specimens, serial sections were cut and stained with
hematoxylin and eosin (H&E). Periodic acid-Schiff reagent (PAS)
and Alcian Blue (AB) staining were performed according to
standard protocols. Immunohistochemical staining was performed
on 5 mm sections of paraformaldehyde fixed, paraffin embedded
tissue samples. The primary antibodies were rat anti-BrdU
(Oxford Biotechnology, Kidlington, UK), rat anti-mouse Ki67
(Dako, Hamburg, Germany), goat anti-E-cadherin (R&D Sytems,
Wiesbaden, Germany), rabbit anti-cleaved caspase 3 (Cell
Signaling, Frankfurt, Germany), rabbit anti-chromogranin A
(Immuno Star, Hudson, USA), goat anti-EphB3 (R&D Systems),
goat anti-villin (Santa Cruz Biotechnology, Wiesbaden, Germany),
rabbit anti-lysozyme (Dako), mouse anti-b-catenin (BD Bioscienc-
es), goat anti-MMP7 (R&D Systems). Isotype controls were run for
every antibody on parallel sections. For antigen unmasking,
sections were either sub-boiled for 20 min at 95uC in 10 mM
sodium citrate buffer (pH 6.0, 10mM; for BrdU, Ki67, E-
cadherin,b-catenin, MMP7, and cleaved caspase 3) or treated
with Target Retrieval Solution (Dako) (for EphB3), with Epitope
Retrieval Solution (Novocastra Laboratories, Newcastle upon
Tyne, UK) (for chromogranin A), with Target Unmasking fluid
(Vector Laboratories, Burlingame, USA) (for Villin) or with
Proteinase Type XXIV (Novocastra) (for lysozyme). Antigen
detection was performed with the ImmPRESS Reagent Kit
Anti-Rabbit or Anti-Goat (Vector Laboratories) or with the
Vectastain ABC-Kit Elite Rat or Goat IgG (Dako). AEC (Zymed
Systems, Berlin, Germany) or DAB (Dako) were used as
chromogen. Slides were finally counterstained with hematoxylin
(Vector Laboratories). For the preparation of semi-thin sections
azur-methylenblue staining was applied. For electron microscopy
freshly prepared segments of small intestine were fixed in 6.25%
glutaraldehyde/Soerensen phosphate buffer for 2 hours. After
E-cadherin and Intestine
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washing in buffered saccharose and osmication (2% distilled water)
for 1 hour, tissues were dehydrated in acetone and then processed
for Epon embedding (polymerisation at 78uC overnight). Ultrathin
sections were counterstained with uranyl and lead citrate. Samples
were studied with a Philips EM 420 transmission electron
microscope.
For confocal immunofluorescence microscopy, mouse tissues
were fixed with 2% paraformaldehyde in 100mM sodium
phosphate buffer, pH 7.4, dehydrated (15% sucrose followed by
30% sucrose) and embedded in Tissue Tek (Sakura Finetek,
Zoeterwoude, The Netherlands). Collagen of tissue slices (16 mm)
was quenched (75 mM NH4Cl, 20mM Glycin in phosphate-
buffered saline, PBS) followed by permeabilization in PBS+3%
bovine serum albumin+1% saponin+0.1% Triton X for 30 min at
room temperature, respectively. Tissues were stained with antibod-
ies against lysozyme (anti-goat, Santa Cruz Biotechnology, Heidel-
berg, Germany), Muc2 (anti-rabbit, Santa Cruz Biotechnology), E-
Cadherin (Alexa Fluor 647, anti-mouse, BD Biosciences), and b-
catenin (Alexa Fluor 546 nm, anti-mouse, BD Biosciences)
overnight at 4uC. Secondary antibodies (anti-goat Alexa Fluor
488 and anti-rabbit Alexa Fluor 546) were from Invitrogen
(Karlsruhe, Germany). Samples were embedded in vectashield with
DAPI (Vector Laboratories) and imaged with a Leica SP5 confocal
microscope (Wetzlar, Germany), and z-stacks were projected onto
three-dimensional reconstructions using Volocity 4.1 software
(Perkin Elmer, Waltham, CA, USA). Figures were assembled with
Photoshop CS (Adobe Systems, Munich, Germany).
In-situ hybridization
Probes for murine Axin2 were generated from EST clone,
corresponding to nucleotides 3472–4256 of the murine Axin2
cDNA (NM_015732.4). In vitro transcription reactions were
performed using 1 mg of linearized DNA, 2 ml of Dig RNA
labeling mix (Roche), 1 ml of ribonuclease inhibitor (Promega,
Mannheim, Germany), and 1.5 ml of T7, T3, or SP6 (Promega,
Germany). In-situ hybridization was performed essentially as
described previously [21].
Quantitative RT-PCR
Total RNA was isolated from intestinal mucosa with Trizol
(Invitrogen) and reverse transcribed using the SuperScript First
Strand kit (Invitrogen). Quantitative RT-PCR was performed in a
Rotorgene 3000 thermocycler (Corbett Life Science, Sydney,
Australia) using primers for cryptidin 1 and 4, Muc2, lysozyme
and GAPDH primer pairs (Metabion, Martinsried, Germany) and
SYBR Green I (Invitrogen). The oligonucleotide sequences used
were: GAPDH, forward, 59-TCATCAACGGGAAGCCCAT-
CAC-39, reverse, 59-AGACTCCACGACATACTCAGCACCG-
39; cryptidin 1 (Defcr1), forward, 59-TCAAGAGGCTGCAAAG-
GAAGAGAAC-39, reverse, 59-TGGTCTCCATGTTCAGCGA-
CAGC-39; cryptidin 4 (Defcr4), forward, 59-CCAGGGGAAGAT-
GACCAGGCTG-39, reverse, 59-TGCAGCGACGATTTCTA-
CAAAGGC-39. Muc2, forward, 59-ACAAAAACCCCAGCAA-
CAAG-39, reverse, 49-RV GAGCAAGGGACTCTGGTCTG-39;
lysozyme, forward, 59-GCCAAGGTCTACAATCGTTGTGA-
GTTG-39, reverse, 59-CAGTCAGCCAGCTTGACACCACG-
39. Differential expression of mRNAs was calculated using the
DDCt method.
Statistical analysis
Groups were compared using two-tailed Student’s t-test and a
two-tailed Mann-Whitney test (Prism 4, GraphPad Software, La
Jolla, CA) and p,0.05 was considered significant.
Results
E-cadherin is required for the maintenance of the
intestinal epithelial architecture
To investigate the role of E-cadherin for the maintenance of the
intestinal epithelial barrier, mice bearing floxed Cdh1 alleles [16]
were crossed into an inducible transgenic background, which uses
the villin promoter to deliver tamoxifen-inducible Cre activity in the
intestine [17]. Villin-Cre-ERT2; Cdh1fl/fl (Cre+Cdh1fl/fl) mice and
respective control mice (Cre+Cdh1fl/+ and Cdh1fl/fl) were subjected to
tamoxifen injections intraperitoneally at 8–10 weeks of age.
Cre+Cdh1fl/fl mice injected for five consecutive days were visibly ill
on day 6, presented with hemorrhagic diarrhea and needed to be
euthanized. In contrast, control mice including Cre+Cdh1fl/+ treated
with tamoxifen and untreated Cre+Cdh1fl/fl mice revealed no
symptoms of illness. While control animals gained some weight
during the six day period, Cre+Cdh1fl/fl mice lost up to 25% of their
body weight (Fig. 1A). Moreover, wet weight and length of small
intestine were considerably reduced (Fig. 1B, C). Microscopic
analysis of H&E-stained sections from the small intestine of
Cre+Cdh1fl/fl mice on the sixth day after start of tamoxifen injection
revealed that the crypt-villus architecture of Cre+Cdh1fl/fl mice
appeared severely altered as compared to Cre+Cdh1fl/+ and Cdh1fl/fl
mice also treated with tamoxifen (Fig. 1D, upper panels). The
phenotype was even more dramatically altered in the colon where
the entire crypt architecture was lost (Fig. 1E, upper panels). In
induced Cre+Cdh1fl/fl mice, E-cadherin immunostaining was grossly
reduced and confined to some cells at the bottom of the crypt in
small intestine (Fig. 1D, lower panels) and to a few cells at the apical
site of the colon compared to control mice (Fig. 1E, lower panels).
Induction of cell death and loss of adherens junctions
and differentiated cells upon loss of E-cadherin
Already on the second day after start of recombination, the
number of apoptotic cells was significantly increased in the small
intestine of Cre+Cdh1fl/fl mice as compared to control animals
(Fig. 2A and C). On the third and fourth days the apoptotic cell
count was further increased with apoptotic cells distributed all over
the crypts and villi (Fig. 2A). In the colon an increase in apoptosis
was observed on the third day (Fig. 2C). On the fifth day, loss of E-
cadherin in the colon led to shedding of cell sheets resulting in loss
of the cellular surface layer (Fig. 2B). Next, the ultrastructure of
cells and cell adhesion molecules was studied by transmission
electron microscopy. This revealed no changes in the intercellular
space and normal appearing microvilli in wild-type and
Cre+Cdh1fl/fl mice (Fig. 2D). Wild-type mice revealed typical
apical junctional complexes consisting of tight junctions, adherens
junctions, and desmosomes (Fig. 2D, left panel). Tight junctions
also appeared unchanged in Cre+Cdh1fl/fl mice treated with
tamoxifen for 3 days. However, adherens junctions including the
rete terminale which represents the connection of the actin
cytoskeleton to the E-cadherin adhesional complex and the
desmosomes were lost from the majority of cell junctions in
recombined mice (Fig. 2D, right panel).
After 5 tamoxifen injections, expression of villin, a marker for
absorptive enterocytes, was confined to the surface area of small
intestine and colon in control mice (Fig. 3A and B, left panels). At
the same time point, this surface staining was reduced and partly
interrupted in recombined Cre+Cdh1fl/fl mice, consistent with a
disintegration of the intestinal epithelial lining (Fig. 3A and B, right
panels). Next, the secretory cell lineages were studied. Histochem-
ical analysis of the colon and small intestine from induced
Cre+Cdh1fl/fl mice with PAS and AB staining revealed that the
number of mucus producing goblet cells was strongly reduced
E-cadherin and Intestine
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(Fig. 3C and 3D, and data not shown). After five days of tamoxifen
treatment the ratio of PAS positive cells per total cells in the crypt-
villus units of the small intestine was reduced to a mean value of
3.060.4% compared to 9.560.8% in controls (p,0.001; n= 4
mice per group; 20 crypt-villus units counted per mouse). Paneth
cells are unique to the small intestine where they reside at the
bottom of the crypts as demonstrated by lysozyme and MMP7
staining (Fig. 3E and F, left panels). After loss of E-cadherin,
lysozyme and MMP7 positive cells were no longer confined to this
location but were scattered all over the crypts and villi in
Cre+Cdh1fl/fl mice (Fig. 3E and F, right panels). Of note, several of
the lysozyme and MMP7 positive cells in the villi were
considerably larger than the cells at the bottom of the crypts.
The number of the scarce enteroendocrine cells, as evaluated by
synaptophysin staining, did not appear to be changed in
Cre+Cdh1fl/fl mice (data not shown).
E-cadherin deficiency abrogates localization and
maturation of secretory cells
As the severe changes of the intestinal epithelium caused by loss
of E-cadherin were not compatible with life, precluding a more
detailed study of E-cadherin’s role in differentiation and
localization of cells, a milder recombination protocol allowing
mice to survive for a longer period was developed. For this
purpose, mice were treated with one daily intraperitoneal injection
of tamoxifen on days 1, 2, 5, and 8. Cre+Cdh1fl/fl mice treated with
Figure 1. E-cadherin is required for the maintenance of the intestinal epithelial architecture. (A) Deletion of E-cadherin results in severe
loss of body weight in Cre+Cdh1fl/fl mice (n = 4) as compared to gender-matched littermates (n = 6) (P,0.005). Necropsy revealed a reduction of (B)
wet weight (P=0.066) and (C) the length of small intestine (P= 0.027). (D and E, upper panels). Comparison of H&E-staining of tamoxifen-treated
control mice (WT) and Cre+Cdh1fl/fl (KO) mice revealed a severe disruption of the epithelial architecture of small intestine (D) and colon (E). (D and E,
bottom panels) Immunostaining for E-cadherin revealed a strong reduction in E-cadherin expression 6 days after start of recombination. Mean values
and standard deviations are shown. Bars, 100 mm.
doi:10.1371/journal.pone.0014325.g001
E-cadherin and Intestine
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this attenuated protocol did not reveal any differences in behavior,
stool habits, or body weight when they were sacrificed on day 12.
Microscopic analysis revealed a less severe array of pathological
alterations in the small intestine and colonic crypts as compared to
the lesions observed in Cre+Cdh1fl/fl mice receiving tamoxifen for
five days. Crypts were elongated and appeared disorganized
(Fig. 4A and B). Expression of E-cadherin was reduced (Fig. 4C
and D). The number of goblet cells was again reduced in both
small intestine and colon (Fig. 5A and B). In the colon, goblet cells
now appeared predominantly in the upper half of the crypts. In
addition, several considerably larger goblet cells were found in
both the small intestine and colon. Paneth cells in the Cre+Cdh1fl/fl
mice were distributed all over the crypts and villi and the number
of Paneth cells at the bottom of the crypts appeared reduced
(Fig. 5C and D). Moreover, in addition to small cells, several of the
lysozyme-positive (Fig. 5C) and MMP7-positive (Fig. 5D) cells in
the villi were much larger than typical Paneth cells. These data
suggest a perturbation of Paneth and goblet cell maturation and
migration after loss of E-cadherin.
As loss of E-cadherin affected localization of differentiated cells,
cell migration was studied in more detail. Mice receiving the
attenuated recombination protocol were injected with BrdU 1 or
24 h before sacrifice at day 12 to mark cells in the S phase. We
found that BrdU-labeled cells in the control mice were exclusively
located in the lower parts of the crypts in the 1 h group (Fig. 5E,
left panel) and only few cells had migrated towards the villi in the
24 h group (Fig. 5E, right panel). In induced Cre+Cdh1fl/fl mice,
analysis of BrdU stained cells identified an expanded proliferative
zone in small intestine (Fig. 5F, left and right panels). The mean
number of BrdU positive cells in control and in Cre+Cdh1fl/fl mice
sacrificed 1 hour after BrdU injection differed significantly
(6.861.4 and 8.561.6 BrdU-positive cells per crypt/villus unit,
respectively; p,0.001). After 24 h the difference was increased
from 11.862.6 in control mice to 18.562.8 BrdU-positive cells
per crypt/villus unit in Cre+Cdh1fl/fl mice (p,0.001). While a
normal cell migration pattern was observed in control mice, with
the majority of proliferating cells being localized close to the crypt
basis 1 h after BrdU injection with a moderate shift towards the
villus 24 h after BrdU injection (Fig. 5G), cell migration was
clearly disturbed in Cre+Cdh1fl/fl mice: 24 h after exposure to
BrdU, proliferating cells were found almost uniformly distributed
along the lower two thirds of the crypt-villus axis (Fig. 5H).
Previous studies have indicated that positioning and maturation
of Paneth cells depend on Wnt signaling and on the EphB gradient
[22,23]. In induced Cre+Cdh1fl/fl mice staining of the Wnt target
gene EphB3 appeared unchanged at the base of the crypts
Figure 2. Induction of cell death and loss of adherens junctions and desmosomes upon loss of E-cadherin. (A and B) Immunostaining of
small intestine (A) and colon (B) for cleaved caspase 3 in control (WT) and Cre+Cdh1fl/fl (KO) mice treated with tamoxifen for 5 days was employed to
identify apoptotic cells (arrowheads). (C) Quantitative analysis of apoptotic cells. 20 crypt-villus units in small intestine and 20 crypts in colon per
animal were analyzed at the indicated time points (n = 4 mice/group). The rate of apoptotic cells is expressed as a percentage of total cell numbers
and mean values and standard error means are shown (*, P,0.005). (D) Transmission electron microscopy of the apical junctional complex of control
(WT) and Cre+Cdh1fl/fl (KO) mice. The intercellular space, microvilli (mv) and cellular substructures appeared unaltered. Compared to control mice, the
junctional complex of Cre+Cdh1fl/fl mice had preserved tight junctions (white arrowhead), but lacked adherens junctions with rete terminale (black
arrowhead) and desmosomes (black arrow). Bars in A and C, 100 mm, in D 0.2 mm.
doi:10.1371/journal.pone.0014325.g002
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compared to controls (Fig. 6A and not shown). In contrast, on
parallel sections in Cre+Cdh1fl/fl mice the lysozyme-positive cells
were scattered over the crypts and villi (Fig. 6B). To determine the
status of Wnt signaling after loss of E-cadherin in more detail in situ
hybridization for the target gene Axin2 (Fig. 6C–E) was
performed. In control mice, Axin2 is expressed at the base of
the crypts (Fig. 6C). On the fourth day following three days of
tamoxifen injections expression of Axin2 was almost completely
lost at this site (Fig. 6D), indicating loss of Wnt signaling activity at
the base of the crypts. The attenuated recombination protocol
resulted in retained but reduced target gene expression (Fig. 6E).
Of note, irrespectively of the recombination protocol used, no
Axin2 positive cells were identified in the upper parts of the crypts
or villi indicating absence of active Wnt signaling in the
mispositioned Paneth cells. This finding was further confirmed
by co-immunostaining for lysozyme and b-catenin: The misposi-
tioned lysozyme-positive cells in the villi revealed strong
membraneous but no nuclear b-catenin staining (data not shown).
Figure 3. Loss of differentiated cells following loss of E-cadherin. (A and B) Staining of absorptive enterocytes for villin. Reduced staining
intensity and disruption of the epithelial lining (arrowheads) in the small intestine (A) and colon (B) of Cre+Cdh1fl/fl (KO) mice as compared to controls
(WT). (C and D) PAS staining revealed a strong reduction of goblet cells (arrowheads) in the colon (C) and small intestine (D) of Cre+Cdh1fl/fl mice four
days after start of induction of recombination as compared to control mice. (E and F) Paneth cells were identified by immunostaining for lysozyme (E)
and MMP7 (F). After five days of tamoxifen treatment, Paneth cells remained confined to the base of the crypt in control mice, but were distributed
throughout the crypt-villus axis in Cre+Cdh1fl/fl mice (arrowheads). Bars in A–F, 100 mm.
doi:10.1371/journal.pone.0014325.g003
E-cadherin and Intestine
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Loss of E-cadherin compromises Paneth and goblet cell
maturation
Next, Paneth and goblet cells were studied in more detail. This
revealed a strong reduction of Paneth cells residing at the bases of
the crypts of Cre+Cdh1fl/fl mice compared to the crypts of control
mice (Fig. 7A and B and Fig 7C, left panel). The majority of crypts
of Cre+Cdh1fl/fl mice contained less than three Paneth cells per
crypt and the remaining Paneth cells were characterized by
dysmorphic and pleomorphic granules with a higher amount of
small granules (Fig. 7C, right panel). Of note, the large lysozyme
and MMP7 positive cells in the villi did not reveal any granules
(data not shown). These findings further support the notion of a
disturbed maturation of Paneth cells in the recombined mice. To
test whether the expression of cryptidines, the most abundant
antibacterial product of Paneth cells was reduced, quantitative
RT-PCR was performed. This revealed a reduction of cryptidin 1
and cryptidin 4 expression by more than 90% (Fig. 7D; p,0.001
and p,0.001, respectively). As expected from the immunohisto-
chemistry studies, expression of lysozyme was also strongly
reduced in the small intestine as was the expression of the most
abundant mucin, Muc 2, in both small intestine and colon
(Fig. 7D). Co-immunofluorescence studies for Muc2 (Fig. 7E and
I), lysozyme (Fig. 7F and J), and E-cadherin (Fig. 7G and K) in
control (Fig. 7E–H) and Cre+Cdh1fl/fl mice (Fig. 7I–L) revealed
cells in the villi simultaneously expressing markers of Paneth and
goblet cells and lacking expression of E-cadherin (Fig.7L). These
cells could not be detected in control mice (Fig. 7H) suggesting that
they represent a common incompletely differentiated precursor of
Paneth and goblet cells.
Impairment of bacterial defense after loss of E-cadherin
Mucus-producing goblet cells and Paneth cells which produce a
wide array of antimicrobial substances are involved in the first line of
bacterial defense. Based on our findings we speculated that
Cre+Cdh1fl/fl mice might have acquired a deficiency in clearing
pathogenic bacteria from the intestinal lumen. To test this
hypothesis, Cre+Cdh1fl/fl mice and control mice were induced
according to the milder tamoxifen protocol and were orally fed with
109 colony forming units (CFU) of bioluminescent Yersinia enterocolitica
as a model for enteropathogenic bacteria on day nine after start of
recombination. Analysis 5 days after infection revealed a strong
increase of bioluminescence in the Peyer’s patches in the Cre+Cdh1fl/fl
mice compared to controls (Fig. 8A). The luminal bacterial load in
small intestine was significantly higher in Cre+Cdh1fl/fl than in control
mice (median number of colony forming yersiniae, 2.116106 vs.
8.006104; p=0.019; Fig. 8B). Moreover, Peyer’s patches were
colonized by significantly higher numbers of yersiniae in Cre+ Cdh1fl/fl
mice compared to control mice (median number of colonies,
8.146106 vs. 3.516105; p=0.01; Fig. 8C).
Discussion
Our findings demonstrate that E-cadherin has an essential role
in intestinal homeostasis and differentiation of secretory cell
lineages. E-cadherin is required for the maintenance of architec-
Figure 4. Impaired expression of E-cadherin results in elongation of crypts and villi. H&E staining of Cre+Cdh1fl/fl (KO) and control mice
(WT) on day 12 after induction of recombination on days 1, 2, 5, and 8, revealed milder changes in the epithelial architecture of small intestine (A) and
colon (B) with elongation of crypts and disorganization of the cellular order. Immunostaining for E-cadherin revealed a reduction in E-cadherin
expression 12 days after start of recombination in KO compared to WT mice in small intestine (C) and colon (D). Bars, 100 mm.
doi:10.1371/journal.pone.0014325.g004
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Figure 5. E-cadherin deficiency abrogates localization and differentiation of cells. (A and B) PAS staining of small intestine (A) and colon
(B) in control mice (WT) and Cre+Cdh1fl/fl mice (KO) analyzed on day 12 following treatment with tamoxifen on days 1, 2, 5, and 8 revealed a reduction
of the number of goblet cells and the appearance of large atypical goblet cells (arrowheads). (C and D) Staining for lysozyme (C) and MMP7 (D) in
control mice (WT) and Cre+Cdh1fl/fl mice (KO) analyzed on day 12 following treatment with tamoxifen as described above revealed a reduction of
Paneth cells at the base of the crypts and the appearance of large positively stained cells in the villi (arrowheads). (E and F) BrdU staining to evaluate
cell migration in control (E) and Cre+Cdh1fl/fl (F) mice 1h (left) and 24h (right) after injection of BrdU. After 24h, BrdU-positive cells were still confined
to the lower parts of the villi in control mice, but positive cells were found throughout the entire crypt-villus axis in Cre+Cdh1fl/fl mice. (G and H)
Position of BrdU-positive cells at 1 h (black bars) and 24 h (open bars) within the crypt-villus axis of control and Cre+Cdh1fl/fl mice. Position 0
represents the base of the crypt. Data were obtained by evaluating 20 crypt-villus units per mouse (n = 2 animals/group). Bars in A and B, 100 mm.
doi:10.1371/journal.pone.0014325.g005
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ture and function of the intestinal epithelium. Cellular adhesion
and regulation of Paneth and goblet cell positioning and
maturation is dependent on the proper expression of E-cadherin.
Therefore, E-cadherin has a key role in maintaining intestinal
epithelial integrity and is indirectly involved in the defense against
enteropathogenic bacteria.
The main function of Paneth cells is the secretion of
microbicidal peptides such a a-defensins which is critical in the
defense against enteropathogenic bacteria [24]. Paneth cells
appear during early postnatal life and they differentiate while
migrating towards the crypt base, where they reside for about 20
days before being cleared by phagocytosis [25]. Maturation and
positioning of Paneth cells has previously been linked to Wnt
signaling [26–29]. It has been suggested that the b-catenin target
gene PPARb/d is an important mediator of Wnt activity in
Paneth cells [30]. Targeted deletion of b-catenin or its target
genes Fz-5 or EphB3 resulted in random scattering of Paneth
cells throughout the crypt-villus axis similar to our findings
[22,26,31,32]. Our data reveal that E-cadherin is required for
correct maturation and placement of Paneth cells, supporting its
role in cell polarization [6]. Interestingly, this occurs without
perturbation of the Ephrin/EphB system. Loss of E-cadherin
might either result in a defect in cell sorting allowing common
Paneth and goblet cell precursors to migrate along the crypt-villus
axis where they are no longer exposed to Wnt signals coinciding
with impaired maturation, or E-cadherin might be required for
anchoring and maturation of Paneth cells at the base of the
crypts. Alternatively, adequate E-cadherin levels may be a
prerequisite for the appropriate differentiation from stem cells
towards goblet and Paneth cells.
Our work also reveals the importance of E-cadherin for the
maintenance of intestinal epithelial homeostasis. The first event in
lineage determination of a progenitor stem cell has been attributed
to Notch signaling. Math 1 (mouse atonal homolog 1) is thought to
be the master switch for differentiation into the two principal
lineages, the absorptive enterocytes and the secretory cells [33,34].
Low levels of Math-1 lead to differentiation of cells towards the
enterocyte lineage, while cells with sustained Math1 expression
develop towards the three secretory cell lineages, Paneth, goblet,
and enteroendocrine cells [3]. For further specification into
enteroendocrine cells the two basic helix-loop-helix factors
neurogenin 3 and NeuroD1 are required [35,36], while Rac1
participates in the fate decision of Math1-positive cells toward
Paneth and goblet cells [37]. The de novo appearance of cells in the
villi of recombined mice which can be detected by Paneth cell and
goblet cell stainings is compatible with the notion that these cells
are common incompletely differentiated precursors of Paneth and
goblet cells. Moreover, these cells fail to stain positive for Wnt
target genes as would be expected in mature Paneth cells. The
simultaneous appearance of incompletely differentiated, misposi-
tioned cells and of normally differentiated cells is most likely due to
the coexistence of E-cadherin deficient and E-cadherin expressing
cells owing to incomplete recombination in the extended
tamoxifen injection protocol. Interestingly, E-cadherin has been
shown to recruit Rac1 which in turn leads to stabilization of the
anchoring of the E-cadherin-catenin complex to actin [38].
Figure 6. Wnt target gene expression in E-cadherin deficient mice. (A and B) Parallel sections of Cre+Cdh1fl/fl mice analyzed on day 12 after
induction of recombination on days 1, 2, 5, and 8 were stained for (A) EphB3 receptor and (B) lysozyme. Bars in A and B, 200 mm. (C–E) In situ
hybridization for the Wnt signaling target gene Axin2 (C–E). Strong staining of crypts in control mice (C), loss of target gene expression on day 4 in
the short time model (D) and reduced expression in long time model on day 12 (E). Bars in C–E, 100 mm.
doi:10.1371/journal.pone.0014325.g006
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Figure 7. Loss of E-cadherin results in disturbed maturation of Paneth cells. (A–B) Staining of ultra thin sections (A) and transmission
electron microscopy (B) revealed a reduced number of Paneth cells at the base of the crypts (arrowheads), altered Paneth cell granule morphology,
and reduced numbers and smaller diameters of Paneth cell granules in Cre+Cdh1fl/fl (left panels) compared to control mice (right panels). Bars in A
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Therefore, loss of E-cadherin expression is likely to result in the
dissociation of Rac1 which may explain the disturbed maturation
and positioning of Paneth and goblet cells observed.
E-cadherin’s function in epithelial homeostasis has probably
been best studied in skin [39–41]. Here, loss of E-cadherin resulted
in death of mice shortly after birth due to dehydration [41], altered
differentiation [39], and disturbed epidermal integrity [40].
Interestingly, E-cadherin was found to be required for tight
junction formation but not desmosome assembly in skin [41]. This
stands in contrast to our findings, where loss of E-cadherin does
not affect the ultrastructure of tight junctions, but results in loss of
desmosomes. This role of E-cadherin for the assembly of other
junctional complexes including desmosomes, tight junctions, and
gap junctions [42] has been suggested to be related to the function
of adherens junctions to establish cell polarity [41]. However, the
reason for this difference observed between skin and intestine is
not clear. It may be due to the relatively short period of time
between start of recombination and analysis of mice in our model
and the fact that loss of E-cadherin occurred in the adult mouse
and not during embryogenesis.
Apoptosis occurred earlier in the small intestine than in the
colon. This is well explained by the stronger activity of the Cre
recombinase in small intestine [17]. However, the epithelial defect,
including sheets of cells shed into to lumen, was more severe in the
colon than in the small intestine. In colon, loss of the entire crypt
epithelium was observed with only the surface epithelium
remaining, in small intestine the phenotype was milder with a
reduction of staining intensity for E-cadherin of the crypt-villus
axis. This suggests a yet unexplained stronger dependence of the
colon epithelium on E-cadherin-dependent cell adhesion than the
small intestine. The stronger effect in colon was also true for the
milder recombination protocol: In colon, expression of E-cadherin
was almost completely lost, whereas in small intestine, expression
was strongly reduced but not lost. Previous in vitro [43] and in vivo
[14] studies have suggested an anti-apoptotic function of E-
cadherin in the intestine. A mouse model expressing a dominant
Figure 8. Impairment of bacterial defense in mice deficient for E-cadherin. Increase of bioluminescence in the Peyer’s patches in Cre+Cdh1fl/fl
mice (A, right panel) compared to control mice (A, left panel) 5 days after oral infection with with 109 CFU of bioluminescent Yersinia enterocolitica.
Colonization of small intestine (B), and Peyer’s Patches (C) of Cre+Cdh1fl/fl and control mice (Cre+Cdh1wt/fl). CFU for each mouse is shown and bars
represent the median value. The limit of detection for yersiniae was 10 CFU for Peyer’s Patches and 50 CFU for small intestine. Statistical significance is
indicated by asteriks.
doi:10.1371/journal.pone.0014325.g008
and B, 20 mm and 2.5 mm, respectively. (C) Quantitative analysis of ultra thin sections revealed a reduced number of Paneth cells per crypt and a
significant increase in the fraction of cryts with ,3 Paneth cells in recombined mice (100 crypts analyzed per mouse for n= 4 mice per group. *,
P,0.005. Measurement of Paneth cell granules in the same mice revealed an increase in small granules in E-cadherin deficient mice. P,0.005. (D)
Expression of cryptidin 1 and 4, lysozyme and Muc2 mRNA was determined by quantitative RT-PCR in the intestinal epithelia of control (n = 5) and
Cre+Cdh1fl/fl (n = 5) mice. (E–L) Co-immunofluorescence for Muc2 (E, I), lysozyme (F, J), E-cadherin (G, K) in control (E–H) and Cre+Cdh1fl/fl mice (I–L). (H,
L) Fusion of pictures. Bars in E–L, 10 mm.
doi:10.1371/journal.pone.0014325.g007
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negative N-cadherin mutant in the mouse intestine resulted in an
increase in epithelial apoptosis rates, increased migration of
enterocytes along the crypt-villus axis and impaired cellular
differentiation [14,44]. These mice displayed a decrease and
intracellular redistribution of E-cadherin, suggesting a role for E-
cadherin in intestinal homeostasis. But as expression of a dominant
negative N-cadherin also interferes with fibroblast growth factor
receptor activation and mitogen-activated protein kinase-extracel-
lular signal-regulated kinase (MAPK-ERK) signaling [45,46], the
precise role of E-cadherin in this context remained unclear.
Another study by the same authors analyzed mouse intestinal
epithelium over-expressing of E-cadherin [47]. Here proliferation
was suppressed, apoptosis was induced, and movement along the
crypt-villus axis was reduced. Targeted deletion of the E-cadherin
interacting protein p120-catenin led to a disrupted intestinal
barrier and impaired epithelial homeostasis [15]. Therefore, our
study by directly targeting E-cadherin now confirms and expands
these previous indirect findings and further clarifies E-cadherin’s
critical role as an anti-apoptotic and survival factor of the intestinal
epithelium.
Interestingly, when it colonizes the intestine, Bacteroides fragilis
can produce the enterotoxin fragilysin which acts as a protease
that disrupts adherens junctions by proteolysis of the extracellular
domain of E-cadherin [48] . This results in an increase in
paracellular permeability and morphological changes of intestinal
epithelial cells [49]. Thus, the effects observed in our model might
resemble the effects of B. fragilis on the intestinal epithelial lining.
Intriguingly, B. fragilis is responsible for .60% of the biofilm mass
in patients with Crohn’s disease but only for 16% of the biofilm
mass in healthy controls [50]. Moreover, B. fragilis has been found
to be one of the predominant bacteria isolated from abdominal
abscesses of patients with Crohn’s disease [51]. The reduced
expression of Paneth cell a-defensins has been described in ileal
Crohn’s disease [52] and expression analyses in human Crohn’s
disease biopsies have demonstrated down-regulation of E-cadherin
[8–10]. Therefore, it has been suggested that Paneth cell
deficiency and disturbed epithelial barrier function are host risk
factors for the development of Crohn’s disease [53,54]. Our results
demonstrate that these two mechanisms of host defense are both
dependent on E-cadherin.
In conclusion, we provide evidence for an essential role of E-
cadherin in intestinal homeostasis. E-cadherin functions as a
survival factor for the small intestinal and colonic epithelium and
its expression is a prerequisite for the maintenance of the epithelial
defense function. These findings further our understanding of the
role of E-cadherin in the pathogenesis of diseases of the intestine
including chronic inflammatory bowel disease and infections with
enteropathogenic bacteria.
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